1. Home
  2. COEP vs GLBS Comparison

COEP vs GLBS Comparison

Compare COEP & GLBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • GLBS
  • Stock Information
  • Founded
  • COEP 2017
  • GLBS 2006
  • Country
  • COEP United States
  • GLBS Greece
  • Employees
  • COEP N/A
  • GLBS N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • GLBS Marine Transportation
  • Sector
  • COEP Health Care
  • GLBS Consumer Discretionary
  • Exchange
  • COEP Nasdaq
  • GLBS Nasdaq
  • Market Cap
  • COEP 27.4M
  • GLBS 23.4M
  • IPO Year
  • COEP N/A
  • GLBS 2007
  • Fundamental
  • Price
  • COEP $10.72
  • GLBS $1.04
  • Analyst Decision
  • COEP
  • GLBS Strong Buy
  • Analyst Count
  • COEP 0
  • GLBS 1
  • Target Price
  • COEP N/A
  • GLBS $3.00
  • AVG Volume (30 Days)
  • COEP 59.5K
  • GLBS 27.3K
  • Earning Date
  • COEP 08-15-2025
  • GLBS 09-11-2025
  • Dividend Yield
  • COEP N/A
  • GLBS N/A
  • EPS Growth
  • COEP N/A
  • GLBS N/A
  • EPS
  • COEP N/A
  • GLBS N/A
  • Revenue
  • COEP $62,874.00
  • GLBS $35,776,000.00
  • Revenue This Year
  • COEP N/A
  • GLBS $5.01
  • Revenue Next Year
  • COEP N/A
  • GLBS $27.86
  • P/E Ratio
  • COEP N/A
  • GLBS N/A
  • Revenue Growth
  • COEP N/A
  • GLBS 17.92
  • 52 Week Low
  • COEP $2.31
  • GLBS $0.99
  • 52 Week High
  • COEP $13.70
  • GLBS $2.21
  • Technical
  • Relative Strength Index (RSI)
  • COEP 55.11
  • GLBS 37.36
  • Support Level
  • COEP $11.30
  • GLBS $1.00
  • Resistance Level
  • COEP $11.46
  • GLBS $1.23
  • Average True Range (ATR)
  • COEP 0.95
  • GLBS 0.06
  • MACD
  • COEP -0.05
  • GLBS -0.01
  • Stochastic Oscillator
  • COEP 38.82
  • GLBS 16.00

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

Share on Social Networks: